Applied DNA Sciences Inc. (APDN)
NASDAQ: APDN
· Real-Time Price · USD
2.31
-0.57 (-19.79%)
At close: Sep 05, 2025, 3:59 PM
2.41
4.33%
After-hours: Sep 05, 2025, 07:53 PM EDT
Applied DNA Sciences Revenue Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Large Scale DNA Production Revenue | 161K | 333.66K | 147.44K | 325.96K | 218.86K | 258.15K | 77.53K | n/a | 271.88K | 253.63K | 127.51K | 23.95K | 67.06K | 32.94K | 2.9K | 4.36K | 12.65K | 18.67K | 1.03M | 161.93K | 20.23K | 250.1K |
| Large Scale DNA Production Revenue Growth | -51.75% | +126.30% | -54.77% | +48.94% | -15.22% | +232.95% | n/a | -100.00% | +7.20% | +98.91% | +432.45% | -64.29% | +103.56% | +1036.32% | -33.48% | -65.54% | -32.28% | -98.19% | +537.06% | +700.27% | -91.91% | n/a |
| Research and Development Services (Over-Time) Revenue | 52.07K | 133.55K | 722.85K | 168.5K | 59.9K | 65.2K | 467.49K | 72K | 135.62K | 87.91K | 126.06K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Services (Over-Time) Revenue Growth | -61.01% | -81.52% | +328.98% | +181.31% | -8.13% | -86.05% | +549.31% | -46.91% | +54.28% | -30.26% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Supply Chain Revenue | 91.32K | 290.23K | n/a | 465.95K | 194.03K | 275.26K | n/a | 145.38K | 242.83K | 27.64K | 411.76K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Supply Chain Revenue Growth | -68.53% | n/a | n/a | +140.14% | -29.51% | n/a | n/a | -40.13% | +778.66% | -93.29% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asia And Other Revenue | 170.79K | -1.12M | 1.36M | 221.75K | 166.44K | 52.77K | 213.14K | 433.72K | 163.12K | 151.34K | 22K | 12.32K | 19.77K |
| Asia And Other Revenue Growth | -115.23% | -182.72% | +511.27% | +33.23% | +215.39% | -75.24% | -50.86% | +165.89% | +7.78% | +587.93% | +78.50% | -37.67% | n/a |
| Europe Revenue | 69.24K | 110.3K | 117.71K | 221.69K | 150.67K | 205.45K | 228.41K | 378.83K | 191.83K | 101.18K | 326.61K | 338K | 294.33K |
| Europe Revenue Growth | -37.23% | -6.30% | -46.90% | +47.14% | -26.66% | -10.05% | -39.71% | +97.49% | +89.59% | -69.02% | -3.37% | +14.84% | n/a |
| U Revenue | 393.49K | 2.68M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| U Revenue Growth | -85.34% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 2.93M | 2.98M | 2.63M | 2.68M | 2.68M | 3M | 3.08M | 3.31M | 3.29M | 3.52M | 2.63M | 3.87M | 3.01M | 3.41M | 4.66M | 2.31M | 3.24M | 3.56M | 3.5M | 2.89M | 2.59M | 2.29M | 2.37M | 2.26M | 2.41M | 2.53M | 3.08M | 3.57M | 2.88M | 2M | 2.59M | 2.79M | 3.4M | 3.23M | 3.9M | 2.62M | 2.71M | 3.12M | 3.55M | 3.66M | 3.51M | 2.9M |
| Selling, General, and Administrative Revenue Growth | -1.77% | +13.30% | -1.91% | +0.21% | -10.71% | -2.73% | -6.84% | +0.57% | -6.54% | +34.18% | -32.22% | +28.51% | -11.69% | -26.80% | +101.63% | -28.63% | -8.93% | +1.62% | +21.13% | +11.63% | +13.28% | -3.70% | +5.04% | -6.14% | -4.81% | -17.96% | -13.70% | +23.92% | +44.35% | -23.00% | -7.07% | -18.00% | +5.34% | -17.19% | +48.71% | -3.11% | -13.24% | -12.21% | -2.83% | +4.26% | +20.93% | n/a |
| Research and Development Revenue | 768.56K | 849.36K | 1.02M | 831.71K | 913.03K | 726.87K | 935.82K | 938.91K | 836.12K | 988.74K | 971.3K | 912.88K | 863.02K | 1.07M | 1.08M | 1.11M | 1.03M | 874.05K | 748.37K | 1.24M | 814.6K | 703.02K | 564.43K | 886.67K | 719.67K | 651.38K | 709.56K | 716.69K | 625.01K | 669.81K | 740.07K | 524.75K | 603.1K | 635.89K | 518.63K | 832.23K | 1.08M | 729.08K | 471.93K | 673.64K | 310.09K | 373.38K |
| Research and Development Revenue Growth | -9.51% | -16.32% | +22.04% | -8.91% | +25.61% | -22.33% | -0.33% | +12.29% | -15.44% | +1.80% | +6.40% | +5.78% | -19.35% | -0.93% | -2.99% | +8.14% | +17.80% | +16.80% | -39.63% | +52.19% | +15.87% | +24.55% | -36.34% | +23.21% | +10.48% | -8.20% | -0.99% | +14.67% | -6.69% | -9.49% | +41.03% | -12.99% | -5.16% | +22.61% | -37.68% | -22.79% | +47.85% | +54.49% | -29.94% | +117.24% | -16.95% | n/a |